AIMEE WYANT: Open Payments
NPI 1437608155 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 10 payments from 8 companies in 2025. Trend: 2023 $561 · 2024 $901 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $50 |
| Edwards Lifesciences Corporation | 1 | $46 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REPATHA, ONPATTRO, UPTRAVI, JARDIANCE, FUROSCIX, LEQVIO, FARXIGA.
Industry payments across PA — which companies pay providers there.
